Nanotechnology Now - Press Release: "QualSec: the Future of Counterterrorism"

Home > Press > QualSec: the Future of Counterterrorism

Abstract:
The Nano-Nose Provides Instantaneous, Mobile Analysis of Biological and Chemical Terror Agents Never before Available

QualSec: the Future of Counterterrorism

NORTH LOGAN, UT | Posted on August 7th, 2008

Since the anthrax attacks of 2001, the U.S. government has been developing a task force to combat biological terrorism. Limitations of technology, however, have crippled our ability to respond to a threat quickly enough to make a real difference. Fortunately, a new technology may offer a solution.

The electronic nose, or e-nose, manufactured by QualSec, Inc. is at the vanguard of biological and chemical terror detection. The handheld, easy-to-use device utilizes breakthroughs in nanotechnology to instantaneously analyze and quantify airborne particles, giving homeland security an edge in the event of biochem attacks.

As noted in Homeland Security Today, the proprietary ROder Technology employed in QualSec's Nano-Nose is unique in its ability to provide real-time on-site analyses never previously offered by electronic nose manufacturers. The Nano-Nose also requires no extensive training for accurate usage and is priced similar devices offered by competitors.

The government's BioWatch system currently in place is a network of sensors built to detect deadly airborne pathogens. William O. Jenkins, Jr. of the Government Accountability office notes that the BioWatch system requires up to 34 hours to detect and confirm pathogens. These are 34 hours that we don't have.

The capability of QualSec's e-nose to function more quickly and accurately in the field than the competition makes it the first choice in the war against terrorism.

####

About QualSec
QualSec believes that this press release contains forward-looking statements as that term is defined by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to view QualSec's filings with the Securities and Exchange Commission, including its annual report on Form 10K for the period ending December 31, 2007. The Company assumes no obligation to update the information contained in this press release.

For more information, please click here

Contacts:
QualSec
Investor Relations, David Stern, 919-928-4510;

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: